Immix Biopharma (IMMX) Current Leases (2024 - 2026)
Quarterly results put Current Leases at $125392.0 for Q1 2026, up 84.9% from a year ago — trailing twelve months through Mar 2026 was $125392.0 (up 84.9% YoY), and the annual figure for FY2025 was $139339.0, up 113.65%.
Immix Biopharma has reported Current Leases over the past 3 years, most recently at $125392.0 for Q1 2026.
- Current Leases reached $125392.0 in Q1 2026 per IMMX's latest filing, down from $139339.0 in the prior quarter.
- Across five years, Current Leases topped out at $141282.0 in Q3 2025 and bottomed at $34284.0 in Q1 2024.
- Median Current Leases over the past 3 years was $67817.0 (2025), compared with a mean of $83874.9.
- Peak annual rise in Current Leases hit 125.28% in 2025, while the deepest fall reached 45.72% in 2025.
- Over 3 years, Current Leases stood at $65219.0 in 2024, then soared by 113.65% to $139339.0 in 2025, then dropped by 10.01% to $125392.0 in 2026.
- Business Quant data shows Current Leases for IMMX at $125392.0 in Q1 2026, $139339.0 in Q4 2025, and $141282.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 720.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 125,392.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,392.00 |
| Dec 31, 2025 | 139,339.00 |
| Sep 30, 2025 | 141,282.00 |
| Jun 30, 2025 | 70,467.00 |
| Mar 31, 2025 | 67,817.00 |
| Dec 31, 2024 | 65,219.00 |
| Sep 30, 2024 | 62,715.00 |
| Jun 30, 2024 | 48,359.00 |
| Mar 31, 2024 | 34,284.00 |